Gelesis Holdings, Inc.
Exhibit 99.22
October 12, 2023
Gelesis Holdings, Inc.
000 Xxxxxxxx Xxxxxx, Xxxxx 0000
Boston, MA 02116
Attention: Xxxxxx Xxxxx; Xxxxx Xxxx
Email: xxxxxx@xxxxxxx.xxx; xxxxx@xxxxxxx.xxx
Re: Notice of Termination
Ladies and Gentlemen:
Reference is made to the Agreement and Plan of Merger, dated as of June 12, 2023 (the “Merger Agreement”), by and among PureTech Health LLC, a Delaware limited liability company (“Parent”), Caviar Merger Sub LLC, a Delaware limited liability company and a wholly owned Subsidiary of Parent (“Merger Sub”), and Gelesis Holdings, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein and not defined have the meanings given to them in the Merger Agreement.
In accordance with Section 8.5 of the Merger Agreement, Parent hereby provides notice to the Company that it is terminating the Merger Agreement pursuant to Section 8.2(a) of the Merger Agreement.
| Sincerely, | ||
| PureTech Health LLC | ||
| By: | /s/ Xxxxxxx Xxxxxxxx | |
| Xxxxxxx Xxxxxxxx | ||
| Chief Executive Officer | ||
cc:
Xxxxxxx Procter LLP
000 Xxxxxxxx Xxxxxx
Boston, MA 02210
Attention: Xxxxx X. Xxxxxxx
Xxxx X. Xxx
Xxxxxxx X. Xxxxxxxx
Email: XXxxxxx@xxxxxxxxxx.xxx
XxxxXxx@xxxxxxxxxx.xxx
XXxxxxxxx@xxxxxxxxxx.xxx
Xxxxxx & Xxxxxxx LLP
000 Xxxxxxxxx Xxxxxx
Boston, MA 02116
Attention: Xxxxx X. Xxxxxxxxx
Xxxxxx X. Xxxxxxxx
Xxx Xxxxxxxx
Email: Xxxxx.Xxxxxxxxx@xx.xxx
Xxxx.Xxxxxxxx@xx.xxx
Xxx.Xxxxxxxx@xx.xxx
